Press Releases
Samsung Biologics : Targeting fast growth in biologics manufacturing
A powerful new px-layer in biopharmaceuticals is moving swiftly to capture a share of the growing biologics contract manufacturing market.?
BIO-Europe 2011 in Duesseldorf marks the introduction of Samsung Biologics to potential partners in Europe. The company’s worldwide tour began at the bio event in the United States in June and included the BIO Japan 2011 world business forum this month in Yokohama.
Ahead of BIO-Europe, Partnering news spoke with Tae-Han Kim, CEO of Samsung Biologics, in order to provide insights into the company’s strategy.
A powerful new px-layer in biopharmaceuticals is moving swiftly to capture a share of the growing biologics contract manufacturing market.
BIO-Europe 2011 in Duesseldorf marks the introduction of Samsung Biologics to potential partners in Europe. The company’s worldwide tour began at the bio event in the United States in June and included the BIO Japan 2011 world business forum this month in Yokohama.
Ahead of BIO-Europe, Partnering news spoke with Tae-Han Kim, CEO of Samsung Biologics, in order to provide insights into the company’s strategy.